Literature DB >> 22030368

Estimation of dengue virus IgM persistence using regression analysis.

Harry E Prince1, Jose L Matud.   

Abstract

Dengue virus IgM persistence was estimated using follow-up sera from 98 patients (60 with primary infections and 38 with secondary infections) whose first-specimen IgM index was strongly positive, suggesting recent disease onset. Regression analysis of the follow-up IgM index versus days between samples yielded a trend line that reached the cut-point index (1.10) at 179 days for the primary infection group and 139 days for the secondary infection group. This difference reflected significantly higher first-sample IgM indices in primary infections than in secondary infections rather than differences in IgM decay rates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030368      PMCID: PMC3232704          DOI: 10.1128/CVI.05425-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  17 in total

Review 1.  Immunopathogenesis of Dengue hemorrhagic fever.

Authors:  A L Rothman; F A Ennis
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

2.  Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil.

Authors:  R M Nogueira; M P Miagostovich; S M Cavalcanti; K B Marzochi; H G Schatzmayr
Journal:  Res Virol       Date:  1992 Nov-Dec

3.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

Review 4.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

Review 6.  Dengue and other emerging flaviviruses.

Authors:  T Solomon; M Mallewa
Journal:  J Infect       Date:  2001-02       Impact factor: 6.072

7.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

8.  Laboratory diagnosis of primary and secondary dengue infection.

Authors:  Stefan Schilling; Diana Ludolfs; Le Van An; Herbert Schmitz
Journal:  J Clin Virol       Date:  2004-11       Impact factor: 3.168

Review 9.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 10.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  20 in total

1.  Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort.

Authors:  Kizzmekia S Corbett; Leah Katzelnick; Hasitha Tissera; Ananda Amerasinghe; Aruna Dharshan de Silva; Aravinda M de Silva
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

Review 2.  Is transfusion-transmitted dengue fever a potential public health threat?

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud
Journal:  World J Virol       Date:  2015-05-12

3.  Persistence of antibody response in chikungunya.

Authors:  Shweta Chelluboina; S Robin; S Aswathyraj; G Arunkumar
Journal:  Virusdisease       Date:  2019-07-24

4.  Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.

Authors:  Harry E Prince; Brent L Seaton; Jose L Matud; Hollis J Batterman
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

5.  Rapid Decline of Zika Virus IgM Antibodies against the NS1 Protein in Imported Israeli Cases.

Authors:  Yaniv Lustig; Neta Zuckerman; Ravit Koren; Shiri Katz-Likvornik; Mayan Yizchaki; Ella Mendelson; Laurence Freedman; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2022-02-21       Impact factor: 2.345

Review 6.  Zika Virus and Pregnancy: A Review of the Literature and Clinical Considerations.

Authors:  Caroline Marrs; Gayle Olson; George Saade; Gary Hankins; Tony Wen; Janak Patel; Scott Weaver
Journal:  Am J Perinatol       Date:  2016-03-03       Impact factor: 1.862

Review 7.  Diagnostic Testing for Zika Virus: a Postoutbreak Update.

Authors:  Elitza S Theel; D Jane Hata
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

8.  The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.

Authors:  Amanda E Calvert; Kalanthe Horiuchi; Karen L Boroughs; Yee T Ong; Kimberly M Anderson; Brad J Biggerstaff; Mars Stone; Graham Simmons; Michael P Busch; Claire Y-H Huang
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

Review 9.  Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs?

Authors:  Stuart D Blacksell
Journal:  J Biomed Biotechnol       Date:  2012-05-10

10.  Dynamics of the Magnitude, Breadth and Depth of the Antibody Response at Epitope Level Following Dengue Infection.

Authors:  Francesca Falconi-Agapito; Karen Kerkhof; Xiomara Merino; Johan Michiels; Marjan Van Esbroeck; Koen Bartholomeeusen; Michael Talledo; Kevin K Ariën
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.